Cochlear | COH - Ebit

Prix De L'Action
172.10
Variation Quotidienne
-1.34 -0.77%
Mensuellement
-6.17%
Annuel
-31.32%
Q2 Prévisions
168.62




Ebit Changement Date
Ansell USD 146.5M 29.2M 2025-12
Avita Medical AUD -10.39M 1.72M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Healius AUD 23.7M 26M 2024-12
Integral Diagnostics AUD 24.99M 5.08M 2024-06
Mayne Pharma AUD -16.2M 13.2M 2024-06
Mesoblast USD -27.75M 14.36M 2025-12
Monash IVF AUD 18M 6.11M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
Regis Healthcare AUD 24.67M 839K 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sigma Healthcare AUD 809K 13.76M 2024-12
Somnomed AUD -1.99M 83.11K 2023-06
Sonic Healthcare AUD 423.94M 80.3M 2024-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12